Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...
A Real-World Study Characterizing Symptoms and Impacts of Fatigue in US Adults with Relapsing Multiple Sclerosis Using a Novel Disease Specific Scale
Background: Fatigue is among the most frequent and disabling symptoms in RMS patients. Objectives: To measure multiple sclerosis (MS)...
Regional MS Summit to Improve Access to High Quality MS Care
Background: In 2006, the Greater Northwest Healthcare Provider Council (HPC) of the National Multiple Sclerosis Society (NMSS) identified a...
Knowledge, Skills, and Confidence of Healthcare Professionals Participating in the Echo MS Program
Background: ECHO MS is a videoconference-based education and case-consultation program that seeks to expand MS expertise. In Fall 2020, the...
Psychoanalytic Telepsychology with MS Patients and Their Support People
Background: N/A Objectives: N/A Methods: N/A Results: N/A Conclusions: N/A This is not a Research-based presentation abstract. I would like...
Baseline Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients Enrolling in the US-Based Corrona MS Registry
Background: An estimated 85% of persons with multiple sclerosis (MS) present with relapsing-remitting (RRMS) disease. There are few large...